Athos Therapeutics
PrivateLast Round
Seed Round
May 15, 2026
Total Funding Raised
$54.25M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Athos Therapeutics is a biotechnology company that develops an artificial intelligence technology platform and therapeutics aimed at patients with inflammatory bowel and autoimmune diseases, utilizing machine learning to discover and develop personalized drug and gene targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Athos Therapeutics Comparables
Compare Athos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Auransa | 82% | |
| Omic.ai | 79% | |
| Genesis Molecular AI | 79% |
Athos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 15, 2026 | ||||
| Series B | Feb 16, 2024 | ||||
| Series A | Nov 15, 2021 | ||||
| Seed | Mar 1, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Raised $10.3M in a seed funding round.
- Mar 10, 2026
CEO to speak at The Montgomery Summit on March 10-11, 2026.
Athos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Athos Therapeutics's valuation, stock price, and market status.
Is Athos Therapeutics a public or private company?
Athos Therapeutics is a private company.
What is the current stock price of Athos Therapeutics?
Athos Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Athos Therapeutics worth (valuation)?
Valuation information for Athos Therapeutics is not publicly available.
Can I buy Athos Therapeutics stock?
Athos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Athos Therapeutics's last funding round?
Athos Therapeutics's most recent funding round was Seed Round on May 15, 2026.
Who are the main investors in Athos Therapeutics?
Investor information for Athos Therapeutics is not publicly disclosed.
Will Athos Therapeutics IPO soon?
No public IPO plans have been announced for Athos Therapeutics.
How can I track Athos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Athos Therapeutics's secondary market activity and sign up for updates.